Medifast, Inc. (MED)

Medifast Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	58.37	89.3	90.93	94.44	87.69	104.18
Short-Term Investments	114.16	77.97	71.42	55.6	-	5.36
Cash & Short-Term Investments	172.53	167.27	162.34	150.04	87.69	109.54
Cash Growth	-0.56%	3.04%	8.20%	71.10%	-19.95%	-37.21%
Inventory	21.2	20.23	42.42	54.59	118.86	180.04
Prepaid Expenses	4.03	9.07	9.64	10.67	16.24	16.33
Other Current Assets	4.17	5.12	-	8.73	-	0.95
Total Current Assets	201.94	201.68	214.4	224.03	222.78	306.87
Property, Plant & Equipment	32.74	38.46	48.68	67.11	75.65	80.59
Long-Term Deferred Tax Assets	-	-	11.46	4.12	5.33	4.4
Other Long-Term Assets	5.09	7.83	9.67	14.65	12.46	6.47
Total Assets	239.76	247.97	284.21	309.91	316.21	398.33

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	38.8	38.36	56.49	39.19	53.12	70.89
Accrued Expenses	-	-	-	36.48	49.03	67.18
Current Portion of Leases	3.08	4.6	6.18	5.89	5.78	6.52
Current Income Taxes Payable	-	-	1.49	-	0.43	-
Current Unearned Revenue	-	-	-	0.57	7.36	8.05
Other Current Liabilities	-	-	-	10.17	25.19	17.19
Total Current Liabilities	41.88	42.96	64.16	92.3	140.89	169.83
Long-Term Leases	17.61	6.09	9.94	16.13	20.28	26.02
Total Liabilities	59.49	49.05	74.1	108.43	161.17	195.85

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	45.15	40.41	33.14	26.57	21.56	12.02
Retained Earnings	135.54	158.27	176.78	174.65	139.85	190.33
Treasury Stock	-	-	-	-	-6.4	-
Comprehensive Income & Other	-0.42	0.23	0.18	0.25	0.02	0.11
Shareholders' Equity	180.28	198.92	210.11	201.48	155.04	202.47
Total Liabilities & Equity	239.76	247.97	284.21	309.91	316.21	398.33

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	20.69	10.69	16.13	22.01	26.05	32.54
Net Cash (Debt)	151.85	156.58	146.22	128.03	61.64	77
Net Cash Growth	-5.83%	7.08%	14.21%	107.70%	-19.95%	-52.85%
Net Cash Per Share	13.71	14.26	13.34	11.72	5.47	6.52
Filing Date Shares Outstanding	10.4	10.31	10.66	10.78	10.78	11.5
Total Common Shares Outstanding	10.4	10.31	10.66	10.78	10.81	11.55
Working Capital	160.06	158.72	150.24	131.73	81.89	137.03
Book Value Per Share	17.33	19.29	19.71	18.69	14.34	17.53
Tangible Book Value	180.28	198.92	210.11	201.48	155.04	202.47
Tangible Book Value Per Share	17.33	19.29	19.71	18.69	14.34	17.53
Land	-	0.35	0.35	0.57	0.57	0.57
Buildings	-	21.74	21.35	24.5	25.91	23.52
Machinery	-	46.15	44.97	50.44	49.38	42.85

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error